Balyasny Asset Management
CRGX

Balyasny Asset Management’s CARGO Therapeutics CRGX Stock Holding History

Balyasny Asset Management’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-374,491
Closed -$1.54M – 2994
2025
Q2 		$1.54M Buy
+374,491
New +$1.6M ﹤0.01% 1866
2024
Q2 		– Sell
-10,464
Closed -$234K – 2646
2024
Q1 		$234K Buy
+10,464
New +$249K ﹤0.01% 2350

Other funds holding CRGX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Balyasny Asset Management's CRGX Position: Q3 2025 in Review

Balyasny Asset Management sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 374,491 shares — an estimated $1.54M sold.

Balyasny Asset Management first reported a position in CRGX in Q1 2024 and held it in 2 quarters. The position peaked at $1.54M in Q2 2025. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

  • Balyasny Asset Management reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 374,491 CARGO Therapeutics shares in Q3 2025, an estimated $1.54M.
  • Balyasny Asset Management first reported a position in CARGO Therapeutics in Q1 2024 and held it in 2 quarters.
  • Balyasny Asset Management's CARGO Therapeutics position peaked at $1.54M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.